BioSpring is a world-leading contract development and manufacturing organization (CDMO) specializing in oligonucleotides for commercial therapies, clinical therapeutic development, diagnostics, and R&D. Over the last 27 years, BioSpring has served the pharmaceutical and biotech industry globally with high-quality products and services under cGMP, advancing the development of innovative manufacturing processes and analytical methods. BioSpring continues to be the industry’s go-to partner for high-quality material, supporting clients’ nucleic acid programs from lab to bedside.